课题基金 / 基金详情

Combining in vivo and in silico screening to identify new classes of anthelmintics targeting rhodoquinone-dependent metabolism

Combining in vivo and in silico screening to identify new classes of anthelmintics targeting rhodoquinone-dependent metabolism
结合体内和计算机筛选来识别针对罗多醌依赖性代谢的新型驱虫药
批准号:
477286
负责人:
Fraser Andrew G
金额:
$7.29万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2022
资助国家:
加拿大
项目状态:
已结题
起止时间:
2022-10-01 至 2023-10-01

项目摘要

项目成果

Fraser Andrew G的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Soil-transmitted helminths (STHs) like hookworms are human parasites. They infect over a billion people causing malnutrition and death, with the greatest effects on children. Drugs for treating STH infections exist but there are few such drugs and resista
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
New drugs and new targets: in search of new classes of drugs that inhibit rhodoquinone-dependent metabolism, an unusual form of anaerobic metabolism that allows parasites to survive in the human gut
  • 批准号:
    479299
  • 项目类别:
    Operating Grants
  • 资助金额:
    $73.56万
  • 财政年份:
    2023
  • 负责人:
    Fraser Andrew G
  • 依托单位:
Reading metabolites with DNA barcodes - establishing barcode structure switching aptamers as a new platform for metabolomics
  • 批准号:
    461939
  • 项目类别:
    Operating Grants
  • 资助金额:
    $47.93万
  • 财政年份:
    2022
  • 负责人:
    Fraser Andrew G
  • 依托单位:
Using C.elegans to understand how the GAR-3 muscarinic acetylcholine receptor modulates other signaling pathways
  • 批准号:
    390288
  • 项目类别:
    Operating Grants
  • 资助金额:
    $66.88万
  • 财政年份:
    2018
  • 负责人:
    Fraser Andrew G
  • 依托单位:
Using C.elegans to learn to predict the personal severity of mutant phenotypes
  • 批准号:
    356723
  • 项目类别:
    Operating Grants
  • 资助金额:
    $90.84万
  • 财政年份:
    2016
  • 负责人:
    Fraser Andrew G
  • 依托单位:
海外基金